Estonia - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Estonia Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use was up 7.2% year on year. At 55 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 22 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Estonia is overtaken by Israel, which was number 21 at 65.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Chile with 52.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands ranked the highest with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 3.9% versus 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria was the worst growing country at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 55.00 |
| 2018 | 51.30 |
| 2017 | 47.60 |
| 2016 | 46.00 |
| 2015 | 42.40 |
How does Estonia rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 21 |
#21
Israel
|
66 | 2019 | +3.3 % | +1.2 % | View data | |
| 22 |
#22
Estonia
|
55 | 2019 | +7.2 % | +7.2 % | View data | |
| 23 |
#23
Chile
|
53 | 2019 | -2.6 % | -3.2 % | View data | |